CrelioHealth vs Orchard Software
Now Clinisys™
Cloud-Native Diagnostics Suite vs Enterprise LIS - Which Fits Your Lab in the USA?
CrelioHealth and Orchard Software (now part of Clinisys) both serve clinical labs in the USA — but they represent different eras and philosophies of lab software. This guide gives lab directors, IT heads, and procurement teams an honest, side-by-side view of both platforms across pricing, features, compliance, and support — before you commit to a demo cycle.
Quick Comparison: CrelioHealth vs Orchard Software (Clinisys)
A high-level snapshot across the criteria that matter most to lab directors, compliance officers, and IT heads evaluating both platforms for USA clinical labs.
Orchard Software (now Clinisys) carries decades of enterprise LIS experience and deep integration breadth across hospital systems in the USA. If your lab is a large hospital core lab, a reference lab running complex esoteric menus, or an academic medical centre that needs a highly configurable enterprise LIS with an extensive validation history, Orchard/Clinisys deserves serious evaluation on its own terms.
Pricing Models Compared
The pricing philosophy between these two platforms differs substantially. CrelioHealth follows a modern SaaS subscription model. Orchard/Clinisys follows a traditional enterprise LIS licensing and services model. Understanding the full cost of ownership, not just the headline license fee, is critical for a fair comparison.
Orchard/Clinisys does not publish standard pricing. Enterprise LIS costs vary significantly based on lab size, interface count, module selection, and scope of services. Always request a fully itemised quote — including implementation, interfaces, annual maintenance, upgrade services, and training — before comparing totals with any SaaS alternative.
Where Both Platforms Align
Despite different deployment models and heritage, CrelioHealth and Orchard/Clinisys share meaningful common ground in core LIS compliance capabilities, analyzer interfacing, and data standards relevant to USA clinical labs.
Which Platform Fits Your Lab?
An honest breakdown of who gets the most value from each platform, based on lab setting, scale, growth stage, and operational priorities.
Choose CrelioHealth if your lab…
- ✓Wants to go live in weeks, not 6–18 months, without a large IT project
- ✓Needs a cloud-native system with no server infrastructure or DBA overhead
- ✓Is scaling from a single site to a multi-location diagnostic chain
- ✓Requires patient-facing report delivery: WhatsApp, SMS, email, and portal
- ✓Needs radiology (PACS/RIS) alongside clinical LIMS in one platform
- ✓Wants built-in AI analytics, TAT prediction, and revenue dashboards
- ✓Needs an integrated reagent and inventory management module
- ✓Wants continuous software updates without validation windows or downtime
- ✓Has international operations requiring HIPAA and GDPR simultaneously
- ✓Is processing high volumes and needs analyzer throughput optimisation tools
Choose Orchard / Clinisys if your lab…
- ✓Is a large hospital core lab or academic medical centre requiring enterprise LIS depth
- ✓Runs a complex esoteric or specialty test menu needing deep send-out management
- ✓Has an existing Orchard/Clinisys deployment and is evaluating upgrade vs. replace
- ✓Requires extensive custom workflow configuration and enterprise-grade scripting
- ✓Has a large IT and informatics team able to manage on-premise infrastructure
- ✓Needs the broadest possible legacy EMR/HIS integration library for a complex hospital network
- ✓Has a multi-year implementation budget and timeline available
- ✓Values a platform with a long USA hospital LIS validation and compliance history
CrelioHealth is the stronger fit for clinical labs that are growing, modernising, or launching multi-site operations and need a cloud-native platform that goes live in weeks, not months. Orchard/Clinisys is the deeper fit for large hospital core labs, reference labs, and academic medical centres where enterprise integration breadth, long compliance history, and complex workflow configuration outweigh the benefits of cloud delivery speed. If you are actively migrating off an Orchard system and evaluating modern alternatives, CrelioHealth's onboarding team has experience handling data migration from legacy LIS platforms.
A modern, cloud-native alternative to legacy enterprise LIS
CrelioHealth is a cloud-native LIMS and full diagnostics suite built for clinical labs, multi-site diagnostic chains, hospital outreach labs, and radiology practices. Orchard Software (now Clinisys™) is a long-established, respected LIS with deep roots in USA hospital labs, reference labs, and multi-site clinical networks. It carries decades of compliance experience and integration depth. Where CrelioHealth differentiates is in its deployment model, speed to value, and modern feature layer: cloud-first infrastructure, AI-driven analytics, a patient engagement platform, continuous software delivery, and a full product suite with LIMS, PACS/RIS, Inventory, and Patient Requisition Platform — all without the enterprise implementation timelines and infrastructure overhead that typically accompany platforms of Orchard's heritage. For labs evaluating a new LIS in 2024 and beyond, both platforms merit serious consideration, but they represent different trade-offs between depth of legacy and speed of innovation.
True cloud architecture
No on-premise servers. Real-time sync across all locations and collection centres — accessible from any device without VPN or IT overhead.
Go live in weeks, not months
2–6 week implementation with a dedicated onboarding specialist and pre-built templates for 15+ USA clinical lab modalities.
AI-driven analytics
Built-in TAT prediction, QC trend dashboards, Westgard auto-validation, and machine throughput analytics are included, not priced as add-ons.
USA compliance ready
CLIA, CAP, COLA, HIPAA controls, and SOC 2 Type II are supported natively for USA clinical labs without a separate compliance configuration project.
Patient-facing layer
Branded patient portal, WhatsApp/SMS/email report delivery, online test booking, and phlebotomist dispatch, built into the platform.
Deep lab integrations
HL7, FHIR, DICOM, 100+ bidirectional analyzer interfaces, Epic/Cerner EMR, insurance billing that is configurable without custom development contracts.
Common Questions: CrelioHealth vs Orchard Software (Clinisys)
Orchard Software was acquired by Clinisys, a global laboratory informatics company, and now operates under the Clinisys brand. The Orchard Harvest LIS product continues to be supported and sold under the Clinisys umbrella. If you were previously evaluating or using Orchard Software, your primary contact is now Clinisys. This comparison covers both the legacy Orchard product line and the broader Clinisys offering in the USA.
Yes, particularly for clinical diagnostic labs, multi-site chains, hospital outreach labs, and growing independent labs that want to avoid the enterprise implementation timeline and infrastructure overhead associated with Orchard/Clinisys. CrelioHealth covers all core clinical LIS workflows: CLIA-compliant QC, order entry, result reporting, billing, and analyzer interfacing, with the added layer of cloud delivery, AI analytics, patient engagement, and continuous updates.
Yes. CrelioHealth supports CLIA compliance natively, including QC documentation with Westgard rules and Levey-Jennings charting, proficiency testing tracking, corrective action records, chain-of-custody logs, and immutable audit trails. CAP and COLA accreditation workflows are also supported. The difference from Orchard/Clinisys is not in compliance coverage, but in how compliance infrastructure is delivered: via continuous cloud updates rather than version-based upgrade cycles.
CrelioHealth typically achieves go-live in 2–6 weeks for most clinical labs. Orchard/Clinisys enterprise deployments, particularly for hospital core labs with complex interfaces and custom workflow configuration, commonly take 6 to 18+ months, plus validation time for regulated environments. The difference is structural: CrelioHealth's cloud-native model and pre-built modality templates eliminate most of the configuration and infrastructure work that drives enterprise LIS timelines.
Yes. CrelioHealth's onboarding team supports data migration from existing LIS platforms, including legacy enterprise systems. The migration process covers historical result data, patient demographics, test configurations, reference ranges, and billing data. A parallel-run period is supported to ensure data continuity and staff confidence before full cutover. Migration scope and timeline are assessed during the implementation scoping phase.
For USA clinical diagnostic lab use cases, CrelioHealth supports the major EMR systems (Epic, Cerner, Athenahealth) via HL7 and FHIR, and interfaces bidirectionally with 100+ clinical analyzer brands, including all major USA market instruments. Orchard/Clinisys has a larger legacy interface library built over decades, particularly for niche hospital system connections and esoteric instrument configurations. For most diagnostic lab deployments, CrelioHealth's interface coverage is sufficient, but for labs with highly specific legacy system dependencies, it is worth validating the interface list directly.
CrelioHealth delivers updates via continuous cloud deployment every 2–4 weeks with zero downtime. For CLIA-regulated labs, this means compliance-relevant updates (QC rule changes, audit trail improvements, CPT code updates) are applied automatically across all accounts simultaneously. Orchard/Clinisys follows a version-based update cycle that on-premise labs must coordinate upgrades with IT, perform validation testing, and manage scheduled downtime windows. The cumulative validation and upgrade coordination cost in regulated environments can be a meaningful hidden expense in the Orchard/Clinisys model.
See how CrelioHealth fits your clinical lab, live.
Book a 30-minute demo with a USA lab implementation specialist. Bring your CLIA requirements, your interface list, and your go-live timeline.